Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 3961.00 | 4227.00 | 0.9371 | 0.8865 | |
| SK-BR-3 | 0 | uM | 8 | 5000.00 | 1743.19 | 5976.00 | 6156.75 | 0.9706 | 0.9675 | |
| SK-BR-3 | 0 | uM | 8 | 5000.00 | 1743.19 | 6218.00 | 6156.75 | 1.0099 | 1.0109 | |
| SK-BR-3 | 0 | uM | 8 | 5000.00 | 1743.19 | 6141.00 | 6156.75 | 0.9974 | 0.9972 | |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 8 | 5000.00 | 1743.19 | 6030.00 | 6156.75 | 0.9794 | 0.9773 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 8 | 5000.00 | 1743.19 | 5987.00 | 6156.75 | 0.9724 | 0.9695 |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 8 | 5000.00 | 1743.19 | 5995.00 | 6156.75 | 0.9737 | 0.9710 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 8 | 5000.00 | 1743.19 | 5211.00 | 6156.75 | 0.8464 | 0.8249 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 8 | 5000.00 | 1743.19 | 3408.00 | 6156.75 | 0.5535 | 0.4452 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 8 | 5000.00 | 1743.19 | 4088.00 | 6156.75 | 0.6640 | 0.5971 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 8 | 5000.00 | 1743.19 | 5960.00 | 6156.75 | 0.9680 | 0.9646 |
| SK-BR-3 | 0 | uM | 8 | 5000.00 | 1743.19 | 6223.00 | 6156.75 | 1.0108 | 1.0118 | |
| SK-BR-3 | 17-AAG | 0.1 | uM | 8 | 5000.00 | 1743.19 | 3448.00 | 6156.75 | 0.5600 | 0.4545 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 8 | 5000.00 | 1743.19 | 6398.00 | 6156.75 | 1.0392 | 1.0427 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 8 | 5000.00 | 1743.19 | 3762.00 | 6156.75 | 0.6110 | 0.5259 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 8 | 5000.00 | 1743.19 | 6159.00 | 6156.75 | 1.0004 | 1.0004 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 8 | 5000.00 | 1743.19 | 5717.00 | 6156.75 | 0.9286 | 0.9202 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 8 | 5000.00 | 1743.19 | 6172.00 | 6156.75 | 1.0025 | 1.0027 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 8 | 5000.00 | 1743.19 | 6138.00 | 6156.75 | 0.9970 | 0.9967 |
| SK-BR-3 | Erlotinib | 1 | uM | 8 | 5000.00 | 1743.19 | 6325.00 | 6156.75 | 1.0273 | 1.0298 |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 8 | 5000.00 | 1743.19 | 6126.00 | 6156.75 | 0.9950 | 0.9945 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 8 | 5000.00 | 1743.19 | 3906.00 | 6156.75 | 0.6344 | 0.5577 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 8 | 5000.00 | 1743.19 | 3273.00 | 6156.75 | 0.5316 | 0.4135 |
| SK-BR-3 | 0 | uM | 8 | 5000.00 | 1743.19 | 5993.00 | 6156.75 | 0.9734 | 0.9706 | |
| SK-BR-3 | 0 | uM | 8 | 5000.00 | 1743.19 | 5845.00 | 6156.75 | 0.9494 | 0.9437 |